Genenta Science SpA ADR (US: GNTA) — Healthcare · Share Price, Chart & Market Data
About: Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.71 (+0.90%)
GNTAGenenta Science SpA ADR
Loading watchlist status…
Trade GNTA now
Genenta Science SpA ADR share price
GNTA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:31 am GMT+0
GNTA price performance
2.638%
5D
-0.211%
1M
-49.773%
YTD
-82.642%
1Y
GNTA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:31 am GMT+0
GNTA details
GNTA Market Signals